Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach

被引:195
作者
Antonini, Angelo [1 ]
Stoessl, A. Jon [2 ]
Kleinman, Leah S. [3 ]
Skalicky, Anne M. [3 ]
Marshall, Thomas S. [4 ]
Sail, Kavita R. [4 ]
Onuk, Koray [4 ]
Odin, Per Lars Anders [5 ,6 ]
机构
[1] Univ Padua, Dept Neurosci, Via Giustiniani 3, Padua, Italy
[2] Pacific Parkinsons Res Ctr, Vancouver, BC, Canada
[3] Evidera, Bethesda, MD USA
[4] AbbVie, N Chicago, IL USA
[5] Lund Univ, Skane Univ Hosp, Dept Neurol, Lund, Sweden
[6] Klinikum Bremerhaven, Bremerhaven, Germany
关键词
Parkinson disease; Delphi technique; Patient identification; Motor fluctuations; Wearing-off; Dyskinesia; Levodopa-Carbidopa Intestinal Gel (LCIG); Deep brain stimulation (DBS); Continuous subcutaneous apomorphine infusion (CSAI); MOTOR FLUCTUATIONS; DYSKINESIA; INFUSION; THERAPIES; SEVERITY; SYMPTOMS; CRITERIA; SAFETY; CARE;
D O I
10.1080/03007995.2018.1502165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Lack of a global consensus on the definition of advanced Parkinson's disease (APD) and considerations for timing of device-aided therapies may result in heterogeneity in care. Objectives: To reach consensus among movement disorder specialists regarding key patient characteristics indicating transition to APD and guiding appropriate use of device-aided therapies in the management of PD symptoms. Methods: A Delphi-panel approach was utilized to synthesize opinions of movement disorder specialists and build consensus. Results: A panel was comprised of movement disorder specialists from 10 European countries with extensive experience of treating PD patients (mean =24.8 +/- 7.2 years). Consensus on indicators of suspected APD and eligibility for device-aided therapies were based on motor symptoms, non-motor symptoms, and functional impairments. Key indicators of APD included: (i) motor-moderate troublesome motor fluctuations, >= 1 h of troublesome dyskinesia/day, >= 2 h "off" symptoms/day, and >= 5-times oral levodopa doses/day; (ii) non-motor-mild dementia, and non-transitory troublesome hallucinations; (iii) functional impairment-repeated falls despite optimal treatment, and difficulty with activities of daily living. Patients with good levodopa response, good cognition, and <70 years of age were deemed as good candidates for all three device-aided therapies. Patients with troublesome dyskinesia were considered good candidates for both levodopa-carbidopa intestinal gel and Deep Brain Stimulation (DBS). PD patients with levodopa-resistant tremor were considered good candidates for DBS. Conclusion: Identifying patients progressing to APD and suitable for device-aided therapies will enable general neurologists to assess the need for referral to movement disorder specialists and improve the quality of care and patient outcomes.
引用
收藏
页码:2063 / 2073
页数:11
相关论文
共 53 条
[1]  
Abbruzzese G, 2012, FUNCT NEUROL, V27, P147
[2]  
[Anonymous], 2010, DIAGN PHARM MAN PARK
[3]  
Antonini A, 2017, DEV CLIN REPORTED SC
[4]   Medical and Surgical Management of Advanced Parkinson's Disease [J].
Antonini, Angelo ;
Moro, Elena ;
Godeiro, Clecio ;
Reichmann, Heinz .
MOVEMENT DISORDERS, 2018, 33 (06) :900-908
[5]   Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes [J].
Antonini, Angelo ;
Yegin, Ashley ;
Preda, Cornelia ;
Bergmann, Lars ;
Poewe, Werner .
PARKINSONISM & RELATED DISORDERS, 2015, 21 (03) :231-235
[6]   A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation [J].
Antonini, Angelo ;
Isaias, Ioannis U. ;
Rodolfi, Giorgia ;
Landi, Andrea ;
Natuzzi, Francesca ;
Siri, Chiara ;
Pezzoli, Gianni .
JOURNAL OF NEUROLOGY, 2011, 258 (04) :579-585
[7]   Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management [J].
Antonini, Angelo ;
Tolosa, Eduardo .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (06) :859-867
[8]   Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinson's Disease [J].
Antonini, Angelo ;
Chaudhuri, K. Ray ;
Martinez-Martin, Pablo ;
Odin, Per .
CNS DRUGS, 2010, 24 (02) :119-129
[9]   Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators: A Systematic Review [J].
Boulkedid, Rym ;
Abdoul, Hendy ;
Loustau, Marine ;
Sibony, Olivier ;
Alberti, Corinne .
PLOS ONE, 2011, 6 (06)
[10]  
BRETTSCHNEIDER C, 2013, PLOS ONE, V0008